Global Health

At Celgene, our commitment to changing the course of human health extends to those living in developed nations and those living in developing parts of the world.

Access Accelerated

Access Accelerated

Access Accelerated is a partnership of 23 biopharmaceutical companies, including Celgene, developing innovative and sustainable solutions to improve access to treatment and care for noncommunicable diseases (NCDs) — such as cancer and heart disease — in low- and middle-income countries.
Learn more

Celgene Cancer Care Links™

Celgene Cancer Care Links™

Celgene Cancer Care Links™ is a new grant program to support cancer healthcare capacity building in resource-constrained countries around the world
Learn more

revolving fund pharmacy

Building Healthcare Capacity for Patients in Africa: AMPATH

For several years, Celgene has worked with the Indiana University School of Medicine, Moi University Teaching and Referral Hospital in Eldoret, Kenya, and a consortium of North American academic health centers to deliver health services, conduct health research, and develop leaders in healthcare for both North America and Africa. The institutional collaborators are collectively named the Academic Model Providing Access to Healthcare (AMPATH).
Learn more

microscope

Neglected Tropical Diseases

CGH is screening our diverse chemical library against the pathogens for neglected tropical diseases.
Learn more

Boudry lab

R&D for Neglected Tropical Diseases

Collaborating closely with disease experts from non- profit and academic institutions around the globe, CGH has utilized the diverse, drug-like properties of the company’s library of more than 400,000 compounds.
Learn more